529 related articles for article (PubMed ID: 24074298)
1. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
3. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
Oelze M; Daiber A; Brandes RP; Hortmann M; Wenzel P; Hink U; Schulz E; Mollnau H; von Sandersleben A; Kleschyov AL; Mülsch A; Li H; Förstermann U; Münzel T
Hypertension; 2006 Oct; 48(4):677-84. PubMed ID: 16940222
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats.
Wang Y; Zhang F; Liu Y; Yin S; Pang X; Li Z; Wei Z
Clin Exp Hypertens; 2017; 39(7):628-639. PubMed ID: 28640644
[TBL] [Abstract][Full Text] [Related]
5. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity.
Mason RP; Kubant R; Jacob RF; Walter MF; Boychuk B; Malinski T
J Cardiovasc Pharmacol; 2006 Jul; 48(1):862-9. PubMed ID: 16891916
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
8. Chronic oxidative-nitrosative stress impairs coronary vasodilation in metabolic syndrome model rats.
Kagota S; Maruyama K; Tada Y; Fukushima K; Umetani K; Wakuda H; Shinozuka K
Microvasc Res; 2013 Jul; 88():70-8. PubMed ID: 23571030
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats.
Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
Hypertens Res; 2014 Mar; 37(3):194-201. PubMed ID: 24132009
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers in the management of hypertension: focus on nebivolol.
Wojciechowski D; Papademetriou V
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
[TBL] [Abstract][Full Text] [Related]
12. TEMPOL enhances the antihypertensive effects of sodium nitrite by mechanisms facilitating nitrite-derived gastric nitric oxide formation.
Amaral JH; Montenegro MF; Pinheiro LC; Ferreira GC; Barroso RP; Costa-Filho AJ; Tanus-Santos JE
Free Radic Biol Med; 2013 Dec; 65():446-455. PubMed ID: 23892053
[TBL] [Abstract][Full Text] [Related]
13. Increased salt sensitivity induced by sensory denervation: role of superoxide.
Song WZ; Chen AF; Wang DH
Acta Pharmacol Sin; 2004 Dec; 25(12):1626-32. PubMed ID: 15569407
[TBL] [Abstract][Full Text] [Related]
14. Nebivolol ameliorates nitric oxide deficient hypertension.
Fortepiani LA; Ortíz MC; Atucha NM; García-Estañ J
ScientificWorldJournal; 2002 Jun; 2():1676-84. PubMed ID: 12806161
[TBL] [Abstract][Full Text] [Related]
15. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
[TBL] [Abstract][Full Text] [Related]
16. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
Wang Y; Zhang M; Liu Y; Liu Y; Chen M
Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
[TBL] [Abstract][Full Text] [Related]
17. Effect of reactive oxygen species and nitric oxide in the neural control of intrarenal haemodynamics in anaesthetized normotensive rats.
Ahmeda AF; Rae MG; Johns EJ
Acta Physiol (Oxf); 2013 Oct; 209(2):156-66. PubMed ID: 23910436
[TBL] [Abstract][Full Text] [Related]
18. Activation of nitric oxide signaling pathway mediates hypotensive effect of Muntingia calabura L. (Tiliaceae) leaf extract.
Shih CD; Chen JJ; Lee HH
Am J Chin Med; 2006; 34(5):857-72. PubMed ID: 17080550
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol combined with tetrahydrobiopterin affects diastolic function in spontaneously hypertensive rats via the nitric oxide/cyclic guanosine monophosphate signalling pathway.
Guan X; Guan X; Lu C; Shang B; Zhao Y; Meng Y; Zhang Z
BMC Pharmacol Toxicol; 2020 Dec; 21(1):84. PubMed ID: 33267901
[TBL] [Abstract][Full Text] [Related]
20. Nebivolol: impact on cardiac and endothelial function and clinical utility.
Toblli JE; DiGennaro F; Giani JF; Dominici FP
Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
